Notify me when Pembroke & Partners LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MTNB | Matinas BioPharma Holdings, Inc. | Common Stock, $0.0001 par value per share | 10% | $10,137,427 | +$9,526,394 | 16,895,712 | +1559% | Robert J. Eide | 08 Apr 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|